Table 2.
Survival of BALB/c mice after vaccination and challenge with LD50 of S. Typhimurium SL1344a
| entry | PS–protein vaccineb | mortality at day 28c | survival rate (%) | hazard ratio (95% CI)d |
p-valuee | vaccine efficacy (%)f |
|---|---|---|---|---|---|---|
| 1 | PBS | 5/9 | 44.4 | – | – | – |
| 2 | 7a (BSA) | 3/10 | 70.0 | 0.435 | 0.278 | 56.5 |
| 3 | 7b (OVA) | 2/9 | 77.8 | 0.395 | 0.239 | 60.5 |
| 4 | 7c (FliC) | 2/10 | 80.0 | 0.259 | 0.098 | 74.1 |
| 5 | 8b (FliC) | 2/9 | 77.8 | 0.395 | 0.239 | 60.5 |
| 6 | 9b (FliC) | 3/10 | 70.0 | 0.378 | 0.216 | 62.2 |
a Mice were orally challenged with 1 × 106 CFU (LD50) S. Typhimurium SL1344 bacteria
b The PS − protein conjugates 7a–9b were prepared from unfractionated LFPS of 23 kDa
c Number of dead mice over total number of test mice
d Cox proportional hazard model results for the risk of death after challenge of S. Typhimurium SL1344 bacteria. CI is confidence interval
e Comparison of survival distribution with the PBS group (negative control). The statistics are performed by log-rank test
f Vaccine efficacy = (1 – hazard ratio) × 100%